Nifty

:

11661.85

Sensex

:

39298.38

75.50 (0.65%)
246.32 (0.63%)

Login

Nifty
Sensex

:
:

11661.85
39298.38

75.50 (0.65%)
246.32 (0.63%)

Venus Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

40/99

BSE: 526953 | NSE: VENUSREM

Watchlist

NSE BSE

34.30

18-Oct-2019

Open
High
Low
Previous Close

33.85
35.30
30.95
29.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

630049
207.79
68.00
18.80

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

42.21
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

337.39
N/A
0.13

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-0.31
-7.75
-7.02

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-7.46
-16.98
-6.23

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
10.23

P:E (Median)

8 Years
5 Years
3 Years

4.40
3.91
-

P:BV (Average)

8 Years
5 Years
3 Years

0.40
0.25
0.20

EV:EBITDA (Average)

8 Years
5 Years
3 Years

5.30
6.09
6.48

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 70.82 65.52 8.09% 86.37 93.21 -7.34% 69.06 93.13 -25.85% 80.89 90.51 -10.63%
Expenses 60.66 55.38 9.53% 83.47 83.81 -0.41% 64.32 80.18 -19.78% 64.38 84.36 -23.68%
EBITDA 10.17 10.14 0.30% 2.90 9.39 -69.12% 4.75 12.95 -63.32% 16.51 6.15 168.46%
EBIDTM 14.36% 15.48% 3.35% 10.08% 6.87% 13.91% 20.41% 6.79%
Other Income 0.42 0.16 162.50% 3.80 0.33 1,051.52% 0.47 0.14 235.71% 1.18 0.12 883.33%
Interest 6.01 7.66 -21.54% 0.00 9.79 -100.00% 9.45 8.43 12.10% 9.14 8.71 4.94%
Depreciation 8.26 8.20 0.73% 8.25 6.15 34.15% 8.25 8.88 -7.09% 8.25 7.52 9.71%
PBT -3.69 -5.56 - -10.52 -6.21 - -12.49 -4.22 - 0.31 -9.96 -
Tax 0.00 0.00 0.00 -0.10 3.16 - -0.55 0.00 - -0.49 0.00 -
PAT -3.69 -5.56 - -10.42 -9.37 - -11.93 -4.22 - 0.80 -9.96 -
PATM -5.21% -8.48% -12.06% -10.06% -17.28% -4.53% 0.99% -11.00%
EPS -2.99 -4.50 - -8.44 -7.60 - -9.67 -3.42 - 0.65 -8.07 -

Description Jun 19 Jun 18 Var% Mar 19 Mar 18 Var% Dec 18 Dec 17 Var% Sep 18 Sep 17 Var%
Net Sales 73.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 63.86 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 9.78 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 13.28% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 6.18 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 8.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -4.07 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -4.07 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM -5.53% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS -3.30 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 307.14 301.84 355.07 375.45 402.69 451.88 526.06 461.34 405.19 356.68 311.51 Net Sales Growth -10.29% -14.99% -5.43% -6.76% -10.89% -14.10% 14.03% 13.86% 13.60% 14.50% Cost Of Goods Sold 182.72 181.78 170.63 186.69 194.64 213.05 298.96 263.27 226.04 199.89 182.20 Gross Profit 124.42 120.06 184.44 188.76 208.05 238.82 227.10 198.07 179.15 156.80 129.31 GP Margin 40.51% 39.78% 51.94% 50.28% 51.67% 52.85% 43.17% 42.93% 44.21% 43.96% 41.51% Total Expenditure 272.83 267.55 311.51 328.16 323.14 364.94 392.83 342.85 299.29 265.60 237.03 Power & Fuel Cost - 3.50 3.02 3.08 2.90 3.28 3.11 2.86 2.49 2.28 1.64 % Of Sales - 1.16% 0.85% 0.82% 0.72% 0.73% 0.59% 0.62% 0.61% 0.64% 0.53% Employee Cost - 30.26 27.82 25.02 25.02 27.26 25.57 23.24 20.58 17.30 14.78 % Of Sales - 10.03% 7.84% 6.66% 6.21% 6.03% 4.86% 5.04% 5.08% 4.85% 4.74% Manufacturing Exp. - 18.98 69.07 75.01 58.94 73.60 20.75 19.72 17.45 16.47 14.09 % Of Sales - 6.29% 19.45% 19.98% 14.64% 16.29% 3.94% 4.27% 4.31% 4.62% 4.52% General & Admin Exp. - 9.79 11.86 12.20 10.85 14.36 13.81 11.10 11.34 10.75 8.25 % Of Sales - 3.24% 3.34% 3.25% 2.69% 3.18% 2.63% 2.41% 2.80% 3.01% 2.65% Selling & Distn. Exp. - 23.24 29.11 26.17 30.78 33.39 30.64 22.66 21.18 18.92 14.80 % Of Sales - 7.70% 8.20% 6.97% 7.64% 7.39% 5.82% 4.91% 5.23% 5.30% 4.75% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 0.00 14.80 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0.05% 0% 0.41% EBITDA 34.33 34.29 43.56 47.29 79.55 86.94 133.23 118.49 105.90 91.08 74.48 EBITDA Margin 11.18% 11.36% 12.27% 12.60% 19.75% 19.24% 25.33% 25.68% 26.14% 25.54% 23.91% Other Income 5.87 4.51 1.06 3.10 0.67 0.55 0.41 0.39 0.38 0.29 0.12 Interest 24.60 25.15 35.32 35.87 36.74 40.70 29.29 24.45 27.26 18.71 13.96 Depreciation 33.01 32.95 32.73 39.32 40.47 44.74 38.61 31.76 23.86 17.91 11.69 PBT -26.39 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 55.15 54.76 48.95 Tax -1.14 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 5.12 7.28 7.90 Tax Rate 4.32% 4.07% -13.49% 18.39% 60.13% -123.04% 7.27% 8.82% 9.28% 13.29% 16.14% PAT -25.24 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 50.03 47.48 41.05 PAT before Minority Interest -25.24 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 50.03 47.48 41.05 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -8.22% -8.98% -7.49% -5.39% 0.30% 1.01% 11.59% 12.39% 12.35% 13.31% 13.18% PAT Growth 0.00% - - - -73.63% -92.53% 6.65% 14.23% 5.37% 15.66% Unadjusted EPS -20.45 -21.97 -21.54 -17.64 1.05 3.97 54.19 58.63 54.43 52.01 48.45

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales - 321.89 372.41 400.04 418.27 463.99 541.56 468.64 409.84 363.09 314.03 Net Sales Growth - -13.57% -6.91% -4.36% -9.85% -14.32% 15.56% 14.35% 12.88% 15.62% Cost Of Goods Sold - 181.95 205.08 227.07 238.51 268.94 300.00 262.26 225.91 201.50 182.31 Gross Profit - 139.94 167.33 172.97 179.77 195.05 241.55 206.38 183.92 161.59 131.71 GP Margin - 43.47% 44.93% 43.24% 42.98% 42.04% 44.60% 44.04% 44.88% 44.50% 41.94% Total Expenditure - 289.37 332.94 349.32 337.11 374.81 403.33 348.53 306.96 273.00 241.27 Power & Fuel Cost - 4.86 4.29 4.14 4.01 3.80 3.38 3.05 2.71 2.72 1.72 % Of Sales - 1.51% 1.15% 1.03% 0.96% 0.82% 0.62% 0.65% 0.66% 0.75% 0.55% Employee Cost - 42.10 39.31 34.27 32.44 32.36 30.45 27.30 24.83 20.38 16.72 % Of Sales - 13.08% 10.56% 8.57% 7.76% 6.97% 5.62% 5.83% 6.06% 5.61% 5.32% Manufacturing Exp. - 21.01 36.10 42.48 15.70 17.29 22.10 20.61 18.18 17.05 14.70 % Of Sales - 6.53% 9.69% 10.62% 3.75% 3.73% 4.08% 4.40% 4.44% 4.70% 4.68% General & Admin Exp. - 11.85 13.52 13.26 11.97 15.67 14.74 11.82 12.14 11.54 9.13 % Of Sales - 3.68% 3.63% 3.31% 2.86% 3.38% 2.72% 2.52% 2.96% 3.18% 2.91% Selling & Distn. Exp. - 27.60 34.65 28.10 34.48 36.75 32.65 23.50 22.98 19.82 15.28 % Of Sales - 8.57% 9.30% 7.02% 8.24% 7.92% 6.03% 5.01% 5.61% 5.46% 4.87% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 0.00 15.28 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0.05% 0% 0.45% EBITDA - 32.52 39.47 50.72 81.16 89.18 138.23 120.11 102.88 90.09 72.76 EBITDA Margin - 10.10% 10.60% 12.68% 19.40% 19.22% 25.52% 25.63% 25.10% 24.81% 23.17% Other Income - 6.09 2.39 4.28 2.01 0.68 0.47 0.44 0.49 0.40 0.16 Interest - 25.41 35.56 36.38 37.98 41.21 29.40 24.63 27.49 18.86 14.07 Depreciation - 33.98 33.83 40.26 41.68 46.00 40.22 33.08 25.02 18.98 12.47 PBT - -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 50.85 52.63 46.38 Tax - -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 3.78 6.41 6.82 Tax Rate - 3.87% -11.48% 21.07% 51.57% -94.72% 6.92% 8.80% 7.43% 12.18% 14.70% PAT - -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 47.08 46.22 39.56 PAT before Minority Interest - -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 47.08 46.22 39.56 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - -8.88% -8.24% -4.27% 0.41% 1.11% 11.87% 12.23% 11.49% 12.73% 12.60% PAT Growth - - - - -67.05% -91.98% 12.20% 21.73% 1.86% 16.84% Unadjusted EPS - -23.15 -24.87 -14.88 1.48 4.51 57.17 58.80 51.22 50.62 46.69

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 340.95 367.99 394.23 444.43 466.24 467.42 392.24 319.11 246.59 179.96 Share Capital 12.34 12.34 12.34 11.44 11.44 11.44 10.54 9.74 9.13 8.47 Total Reserves 328.61 355.65 381.89 432.99 454.79 455.97 376.92 300.35 233.27 169.36 Non-Current Liabilities 136.75 157.89 179.52 212.03 221.50 161.27 147.18 113.50 99.41 156.97 Secured Loans 60.88 86.02 112.69 134.55 150.91 114.28 103.89 75.45 65.97 91.67 Unsecured Loans 55.20 50.84 49.13 56.47 51.34 25.22 25.22 23.68 22.02 57.73 Long Term Provisions 5.32 4.50 4.29 3.79 3.78 3.31 2.91 2.50 1.94 0.00 Current Liabilities 254.46 222.69 193.71 177.59 157.06 207.33 190.06 154.13 124.69 22.46 Trade Payables 33.41 27.19 30.56 23.90 25.76 28.14 17.87 12.33 6.11 6.29 Other Current Liabilities 107.61 76.96 45.70 36.63 13.99 54.12 57.88 43.22 40.27 2.99 Short Term Borrowings 108.92 117.23 115.70 115.09 115.40 110.08 95.68 83.24 63.17 0.00 Short Term Provisions 4.52 1.32 1.76 1.97 1.91 14.99 18.63 15.33 15.14 13.18 Total Liabilities 732.16 748.57 767.46 834.05 844.80 836.02 729.48 586.74 470.69 359.39 Net Block 346.89 369.93 389.38 433.52 425.77 416.09 380.92 335.86 274.04 210.84 Gross Block 674.06 669.01 655.78 660.61 612.50 555.61 481.83 405.01 319.32 239.08 Accumulated Depreciation 327.17 299.08 266.40 227.09 186.73 139.52 100.91 69.15 45.28 28.24 Non Current Assets 478.57 496.54 517.54 575.53 618.72 567.61 500.20 413.61 331.63 236.48 Capital Work in Progress 64.76 64.76 66.25 80.37 78.30 67.80 47.81 23.00 15.31 0.86 Non Current Investment 0.14 28.74 28.74 28.74 28.74 28.74 28.74 28.74 28.37 24.79 Long Term Loans & Adv. 66.78 33.11 33.17 32.90 85.91 54.98 42.74 26.01 13.91 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 253.59 252.04 249.93 258.53 226.08 268.41 229.28 173.13 139.07 121.85 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 140.94 135.98 139.69 137.69 140.44 141.46 126.40 96.19 75.43 61.94 Sundry Debtors 31.39 44.15 41.91 53.88 59.37 62.80 53.11 44.33 36.41 31.93 Cash & Bank 1.28 3.64 3.15 3.04 3.52 4.38 6.26 2.91 2.91 2.00 Other Current Assets 79.98 0.00 0.00 0.00 22.76 59.77 43.51 29.70 24.31 25.97 Short Term Loans & Adv. 74.83 68.27 65.18 63.91 22.76 59.77 43.51 29.70 24.11 25.97 Net Current Assets -0.87 29.35 56.22 80.94 69.02 61.08 39.21 19.00 14.38 99.38 Total Assets 732.16 748.58 767.47 834.06 844.80 836.02 729.48 586.74 470.70 359.40

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 332.52 361.91 388.67 437.62 456.68 461.61 379.13 307.29 236.92 171.18 Share Capital 12.34 12.34 12.34 11.44 11.44 11.44 10.54 9.74 9.13 8.47 Total Reserves 320.18 349.57 376.33 426.18 445.24 450.17 363.81 288.53 223.59 160.58 Non-Current Liabilities 136.68 158.47 179.52 212.05 221.55 161.75 147.18 113.51 99.41 156.96 Secured Loans 61.29 86.60 112.69 134.57 150.95 114.76 103.89 75.45 65.97 91.67 Unsecured Loans 54.73 50.84 49.13 56.47 51.34 25.22 25.22 23.68 22.02 57.73 Long Term Provisions 5.32 4.50 4.29 3.79 3.78 3.31 2.91 2.50 1.94 0.00 Current Liabilities 263.62 230.47 196.81 193.14 162.83 210.99 191.25 153.22 124.53 21.95 Trade Payables 36.00 29.33 29.73 25.14 29.56 31.22 18.76 12.55 7.02 6.36 Other Current Liabilities 110.30 78.56 46.16 42.71 15.96 54.70 58.18 43.44 40.07 3.48 Short Term Borrowings 112.80 121.26 119.16 123.32 115.40 110.08 95.68 83.24 63.17 0.00 Short Term Provisions 4.52 1.32 1.76 1.97 1.91 14.99 18.63 13.99 14.27 12.11 Total Liabilities 732.82 750.85 765.00 842.81 841.06 834.35 717.56 574.02 460.86 350.09 Net Block 364.45 389.20 406.18 452.48 443.65 439.46 401.42 355.39 293.28 229.50 Gross Block 707.02 703.32 686.50 679.57 641.12 587.38 511.00 430.25 343.15 260.85 Accumulated Depreciation 342.57 314.11 280.32 227.09 197.47 147.93 109.58 74.87 49.86 31.36 Non Current Assets 467.39 487.08 505.60 565.75 607.85 562.24 491.97 404.40 322.49 230.36 Capital Work in Progress 64.76 64.76 66.25 80.37 78.30 67.80 47.81 23.00 15.31 0.86 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 38.18 33.11 33.17 32.90 85.91 54.98 42.74 26.01 13.91 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 265.43 263.77 259.41 277.07 233.21 272.11 225.58 169.63 138.37 118.66 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 142.73 138.17 140.60 143.29 142.87 142.26 128.03 96.82 75.43 61.94 Sundry Debtors 38.04 47.27 47.29 61.59 63.22 64.99 47.11 40.10 35.74 28.30 Cash & Bank 2.81 3.98 3.56 7.07 3.62 4.41 6.36 2.95 3.12 2.40 Other Current Assets 81.85 0.00 0.00 0.00 23.51 60.47 44.08 29.77 24.07 26.03 Short Term Loans & Adv. 76.70 74.34 67.96 65.12 23.51 60.47 44.08 29.77 23.87 26.03 Net Current Assets 1.81 33.30 62.59 83.93 70.38 61.12 34.33 16.41 13.84 96.72 Total Assets 732.82 750.85 765.01 842.82 841.06 834.35 717.55 574.03 460.86 350.09

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 43.65 51.58 61.77 41.91 66.76 52.56 50.66 38.06 39.34 35.25 PBT -28.26 -23.42 -24.80 3.01 2.04 65.73 62.67 55.15 54.76 48.95 Adjustment 59.20 64.73 69.30 53.72 81.90 35.95 39.38 27.76 23.16 11.62 Changes in Working Capital 12.71 10.27 17.27 -14.82 -17.18 -49.12 -51.39 -44.85 -38.58 -25.33 Cash after chg. in Working capital 43.65 51.58 61.77 41.91 66.76 52.56 50.66 38.06 39.34 35.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -11.27 -11.48 -18.06 3.20 -67.15 -93.75 -102.47 -93.63 -98.23 -52.35 Net Fixed Assets -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 -93.38 -94.69 -52.36 Net Investments 28.60 0.00 0.00 0.00 0.00 0.00 0.00 -0.37 -3.58 0.00 Others -34.82 0.26 -37.01 53.38 0.24 0.02 -0.84 0.12 0.04 0.01 Cash from Financing Activity -34.74 -39.61 -43.60 -45.59 -0.47 39.31 55.15 55.57 59.80 17.81 Net Cash Inflow / Outflow -2.36 0.49 0.11 -0.48 -0.86 -1.88 3.35 0.00 0.91 0.71 Opening Cash & Equivalents 3.64 3.15 3.04 3.52 4.38 6.26 2.91 2.91 2.00 1.29 Closing Cash & Equivalent 1.28 3.64 3.15 3.04 3.52 4.38 6.26 2.91 2.91 2.00

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 45.33 51.44 58.93 46.88 67.80 52.65 52.15 41.67 37.35 31.68 PBT -29.73 -27.53 -21.64 3.51 2.65 69.08 62.84 50.85 52.63 46.38 Adjustment 60.72 66.31 70.61 56.41 83.56 37.21 40.72 29.96 24.74 12.40 Changes in Working Capital 14.33 12.66 9.96 -13.04 -18.40 -53.65 -51.41 -39.14 -40.02 -27.10 Cash after chg. in Working capital 45.33 51.44 58.93 46.88 67.80 52.65 52.15 41.67 37.35 31.68 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -11.33 -12.31 -18.32 2.92 -67.18 -94.66 -103.89 -95.15 -96.43 -51.22 Net Fixed Assets -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 -93.38 -94.69 -52.36 Net Investments 28.60 0.00 0.00 0.00 0.00 0.00 0.00 -0.37 -3.58 0.00 Others -34.88 -0.57 -37.27 53.10 0.21 -0.89 -2.26 -1.40 1.84 1.14 Cash from Financing Activity -35.17 -38.71 -44.13 -46.35 -1.42 40.06 55.15 53.31 59.80 20.34 Net Cash Inflow / Outflow -1.17 0.42 -3.51 3.46 -0.79 -1.95 3.41 -0.17 0.72 0.81 Opening Cash & Equivalents 3.98 3.56 7.07 3.62 4.41 6.36 2.95 3.12 2.40 1.59 Closing Cash & Equivalent 2.81 3.98 3.56 7.07 3.62 4.41 6.36 2.95 3.12 2.40

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 276.25 298.16 319.42 388.42 407.48 408.51 367.54 318.30 265.52 208.62 ROA -3.66% -3.51% -2.53% 0.14% 0.54% 7.79% 8.68% 9.46% 11.44% 12.47% ROE -7.65% -6.98% -4.83% 0.26% 0.97% 14.26% 16.38% 18.11% 22.65% 26.01% ROCE -0.48% 1.73% 1.50% 5.11% 5.55% 13.40% 14.49% 16.94% 19.29% 20.94% Fixed Asset Turnover 0.45 0.54 0.57 0.63 0.77 1.02 1.04 1.12 1.28 1.47 Receivable days 45.68 44.23 46.56 51.33 49.34 40.15 38.45 36.30 34.91 36.77 Inventory Days 167.43 141.69 134.83 126.05 113.85 92.77 87.83 77.16 70.17 62.32 Payable days 37.63 31.43 27.90 25.33 24.89 20.07 14.84 10.66 8.22 9.26 Cash Conversion Cycle 175.48 154.49 153.50 152.04 138.30 112.85 111.44 102.80 96.86 89.83 Total Debt/Equity 0.86 0.82 0.78 0.74 0.68 0.62 0.70 0.71 0.77 0.85 Interest Cover -0.12 0.34 0.31 1.08 1.05 3.24 3.56 3.02 3.93 4.51

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 269.43 293.23 314.92 382.47 399.13 403.43 355.10 306.18 254.92 198.25 ROA -3.85% -4.05% -2.12% 0.20% 0.62% 8.29% 8.87% 9.10% 11.40% 12.23% ROE -8.23% -8.18% -4.13% 0.38% 1.12% 15.38% 17.04% 17.73% 23.07% 26.17% ROCE -0.67% 1.17% 2.00% 5.35% 5.74% 14.06% 14.85% 16.47% 19.24% 20.58% Fixed Asset Turnover 0.46 0.54 0.59 0.63 0.76 0.99 1.00 1.06 1.20 1.34 Receivable days 48.37 46.34 49.67 54.45 50.42 37.72 33.88 33.71 32.14 35.56 Inventory Days 159.26 136.61 129.51 124.86 112.15 90.94 87.34 76.56 68.94 61.82 Payable days 37.91 30.30 26.74 26.74 27.25 21.28 15.09 11.03 8.63 10.98 Cash Conversion Cycle 169.72 152.65 152.44 152.57 135.32 107.37 106.14 99.25 92.44 86.40 Total Debt/Equity 0.90 0.85 0.80 0.77 0.70 0.63 0.72 0.74 0.80 0.89 Interest Cover -0.17 0.23 0.41 1.09 1.06 3.35 3.55 2.85 3.79 4.30

Top Investors:

Annual Reports:

News Update:

Venus Remedies to sell patented product Elores to Cipla for Indian Territory
18th Oct 2019, 10:21 AM

This association with Cipla will enable greater patient access of Elores in India
Read More
Venus Remedies - Quarterly Results
13th Aug 2019, 18:06 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback